KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teladoc Health (TDOC) Restructuring Costs (2016 - 2026)

Teladoc Health's Restructuring Costs history spans 12 years, with the latest figure at $1.1 million for Q1 2026.

  • On a quarterly basis, Restructuring Costs fell 51.37% to $1.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $17.7 million, a 20.34% decrease, with the full-year FY2025 number at $18.8 million, down 7.71% from a year prior.
  • Restructuring Costs hit $1.1 million in Q1 2026 for Teladoc Health, down from $12.0 million in the prior quarter.
  • Over the last five years, Restructuring Costs for TDOC hit a ceiling of $19.1 million in Q4 2024 and a floor of -$1.6 million in Q4 2022.
  • Historically, Restructuring Costs has averaged $4.0 million across 5 years, with a median of $2.7 million in 2025.
  • Biggest five-year swings in Restructuring Costs: plummeted 134.59% in 2022 and later surged 486.6% in 2025.
  • Tracing TDOC's Restructuring Costs over 5 years: stood at -$1.6 million in 2022, then surged by 370.26% to $4.3 million in 2023, then skyrocketed by 347.4% to $19.1 million in 2024, then crashed by 37.03% to $12.0 million in 2025, then tumbled by 91.14% to $1.1 million in 2026.
  • Business Quant data shows Restructuring Costs for TDOC at $1.1 million in Q1 2026, $12.0 million in Q4 2025, and $1.9 million in Q3 2025.